Back to top
more

AveXis, Inc. (AVXS)

(Real Time Quote from BATS)

$217.83 USD

217.83
NA

+0.18 (0.08%)

Updated May 14, 2018 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Options Traders Expect Huge Moves in AveXis (AVXS) Stock

by Zacks Equity Research

AveXis (AVXS) needs investors to pay close attention to the stock based on moves in the options market lately.

    Novartis (NVS) Beats Earnings and Revenue Estimates in Q1

    by Zacks Equity Research

    Novartis reported encouraging results for the first quarter as sales and earnings both topped expectations on Cosentyx and Entresto strength.

      Do Options Traders Know Something About AveXis (AVXS) Stock We Don't?

      by Zacks Equity Research

      Investors need to pay close attention to AveXis (AVXS) stock based on the movements in the options market lately.

        Agios Pharmaceuticals Shares Rise on Buyout Speculation

        by Zacks Equity Research

        Agios (AGIO) share price shoots up on probable acquisition by other biggies in the biotech industry. This optimism follows the news of Novartis striking a deal to buy gene therapy company, AveXis.

          Company News For Apr 10, 2018

          by Zacks Equity Research

          Companies in the news are: PME,CBS,WATT,AVXS,NVS

            AveXis (AVXS) Enters Overbought Territory

            by Zacks Equity Research

            AveXis, Inc. (AVXS) has moved higher as of late, but there could definitely be trouble on the horizon for this company

              Novartis Inks $8.7 Billion Gene Therapy Deal to Buy AveXis

              by Zacks Equity Research

              Novartis (NVS) signs a contract to purhcase the U.S. based clinical stage gene therapy company, AveXis, Inc for a cash-tender offer of $218 per share.

                Why AveXis (AVXS) Could Be Positioned for a Slump

                by Zacks Equity Research

                AveXis (AVXS) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

                  AveXis (AVXS) Jumps: Stock Rises 7.1%

                  by Zacks Equity Research

                  AveXis, Inc.(AVXS) was a big mover last session, as the company saw its shares rise over 7% on the day.

                    AveXis (AVXS) Surges: Stock Moves 5% Higher

                    by Zacks Equity Research

                    AveXis (AVXS) was a big mover last session, as the company saw its shares rise over 5% on the day.

                      What Falling Estimates & Price Mean for AveXis, Inc. (AVXS)

                      by Zacks Equity Research

                      It seems wise to sell the AveXis, Inc. (AVXS) stock at this moment as its both estimates and price have been witnessing downward revision.

                        AveXis, Inc. (AVXS) Looks Good: Stock Moves 15.4% Higher

                        by Zacks Equity Research

                        AveXis, Inc. (AVXS) shares rise above 15% in the last trading session.

                          Will 2017 IPO Market Revive After Dismal 2016?

                          by Zacks Equity Research

                          Proceeds from the U.S. Initial Public Offerings (IPOs) slowed down in 2016, as 105 IPOs raised only $18.8 billion, which was the lowest since 2003.